[Advances in the ultrasound diagnosis of prostate cancer]
- PMID: 17283710
- DOI: 10.4321/s0004-06142006001000004
[Advances in the ultrasound diagnosis of prostate cancer]
Abstract
Objectives: Ultrasound guided biopsies are the mainstay in the diagnosis of prostate cancer. With the aim of improving diagnostic performances different protocols of prostate biopsy have been designed. The addition of vascular contrasts to the ultrasound allows for identification of hypervascular regions more likely to be cancer. The new ultrasound modalities enhance contrast signal and specifically differentiate its signal from the tissue reflections.
Method: A non structured review of the literature was conducted on the utility of the different ultrasound modalities and types in targeting the biopsies of the prostate.
Results: There are four types of ultrasound guided biopsies of the prostate: ultrasound guided biopsy of hypoechoic nodes, systematic biopsy protocols, Doppler guided biopsy and Contrast Enhanced Doppler guided biopsy. In spite of the broad literature only few series possess a methodologically correct design related to the use of reference standards. The diagnostic performance of each one of the different types of biopsy varies widely. Sensitivity and specificity of ultrasound guided biopsy of hypoechoic nodes depends on the type of population included in the study but in general its positive predictive value is low. The protocols of systematic biopsy increase the sensitivity of the prostate biopsy but still specificity is low. The Doppler techniques offer a marginal benefit. Contrast Enhanced Doppler guided biopsies series have reported only a slightly increase in sensitivity and a significant improvement of the odds risk for diagnostic of prostate cancer. New arising ultrasound modalities present with promising preliminary results.
Conclusions: Ultrasound guided biopsy have an acceptable sensitivity in the diagnosis of prostate cancer, however specificity is overall low. Among the different ultrasound techniques only Contrast Enhanced Ultrasound improves significantly the diagnostic risk of the biopsy although the sensitivity remains quite stable. New specific contrast ultrasound techniques are currently under investigation.
Similar articles
-
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.Eur Radiol. 2006 Apr;16(4):927-38. doi: 10.1007/s00330-005-0035-y. Epub 2006 Jan 4. Eur Radiol. 2006. PMID: 16391907 Review.
-
[Advances in ultrasound techniques for the diagnosis and staging of prostate cancer. Elastography, Doppler ultrasound, ultrasound contrast media, ultrasound quantification media and MRI fusion].Arch Esp Urol. 2015 Apr;68(3):307-15. Arch Esp Urol. 2015. PMID: 25948802 Review. Spanish.
-
Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?Eur J Radiol. 2016 Oct;85(10):1778-1785. doi: 10.1016/j.ejrad.2016.07.021. Epub 2016 Aug 1. Eur J Radiol. 2016. PMID: 27666616
-
Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer.J Urol. 2011 Jun;185(6):2126-31. doi: 10.1016/j.juro.2011.02.014. Epub 2011 Apr 15. J Urol. 2011. PMID: 21496853
-
Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.BJU Int. 2011 Dec;108(11):1723-7. doi: 10.1111/j.1464-410X.2011.10199.x. Epub 2011 Jul 14. BJU Int. 2011. PMID: 21756276 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical